Altogether, this meta‐analysis highlighted that SPARC mRNA is expressed by different CAF subtypes, including myofibroblasts and inflammatory‐like CAFs involved in different tumor‐related processes, such as matrix remodeling, inflammation and resistance to therapy in TNBC.9, 11. The gene discussed is SPARC; the disease is neoplasm.